#ALS AWARENESS #LouGehrigsDisease #PARKINSONS
158.4K views | +1 today
Follow
#ALS AWARENESS #LouGehrigsDisease #PARKINSONS
Health

#ALS AWARENESS #LouGehrigsDisease #PARKINSONS

Raising ALS | Lou Gehrigs Disease & Parkinsons Disease AWARENESS to the NEXT LEVEL!
Curated by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
Your new post is loading...
Your new post is loading...
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
March 16, 2015 6:34 PM
Scoop.it!

Neuralstem Announces Topline Results Of Phase II ALS Trial

Neuralstem Announces Topline Results Of Phase II ALS Trial | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From finance.yahoo.com - March 16, 2015 6:34 PM
GERMANTOWN, Md., March 12, 2015 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced top line data from the Phase II trial of NSI-566 spinal cord-derived neural stem cells under development for the treatment of amyotrophic lateral sclerosis (ALS). The maximum tolerated dose of 16 million transplanted cells and the surgery was well tolerated. Secondary efficacy endpoints at nine months post-surgery indicate a 47% response rate to the stem cell treatment, as measured by either near-zero slope of decline or positive slope of ALSFRS score in seven out of 15 patients and by either a near-zero decline, or positive strengthening, of grip strength in seven out of 15 patients. Grip strength is an indicator of direct muscle strength of the lower arm.
more...
No comment yet.
Sign up to comment
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
May 20, 2014 9:12 AM
Scoop.it!

New laws give dying patients ‘right to try’ unproven drugs

New laws give dying patients ‘right to try’ unproven drugs | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From www.washingtonpost.com - May 20, 2014 9:12 AM
Three states are poised to let the terminally ill bypass FDA paperwork, assuming the drugmakers are game.
more...
No comment yet.
Sign up to comment
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
April 17, 2013 5:22 PM
Scoop.it!

Neuralstem Press Release: FDA Approval to Commence Phase II Stem Cell Trial for Lou Gehrigs Disease | ALS

Neuralstem Press Release: FDA Approval to Commence Phase II Stem Cell Trial for Lou Gehrigs Disease | ALS | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From investor.neuralstem.com - April 17, 2013 5:22 PM
Neuralstem Receives FDA Approval To Commence Phase II Stem Cell Trial In Amytrophic Lateral Sclerosis
more...
No comment yet.
Sign up to comment
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
December 1, 2012 7:59 AM
Scoop.it!

ALS patient is living his second miracle

ALS patient is living his second miracle | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From www.crainsdetroit.com - December 1, 2012 7:59 AM
Ted Harada is living his second miracle right now, savoring every minute of every hour of it for as long as it lasts.
more...
No comment yet.
Sign up to comment
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
September 13, 2012 3:45 PM
Scoop.it!

Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat Spinal Cord Injury......

Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat Spinal Cord Injury...... | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From www.redorbit.com - September 13, 2012 3:45 PM
Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat Spinal Cord Injury......
more...
No comment yet.
Sign up to comment
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
June 10, 2014 3:18 PM
Scoop.it!

Who should have say on a patient taking experimental drugs?

Who should have say on a patient taking experimental drugs? | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From m.washingtonexaminer.com - June 10, 2014 3:18 PM
Darcy Olsen, president of the Arizona-based Goldwater Institute, and Richard Garr, president of Neuralstem, a biotech company, wrote Right to Try experimental drugs in USA Today. They pointed out that this year, more than 5,000 Americans will lose their battle with ALS, commonly known as Lou Gehrig's disease. Up until recently, there was no medicine on the market that significantly improved the lives of ALS patients. But now there is one in clinical trials that holds considerable promise, but it has not been granted Food and Drug Administration approval. The average amount of time it takes to get a drug through the FDA approval process is 10 years. That's time that terminal patients don't have.
more...
MPCIRHC.ORG's curator insight, July 16, 2014 11:24 AM

Unfortunately, when an unfortunate event happens in the USA, the less informed cease upon that event to involve government more into the lives of others. This seems to be more of a CYA knee jerk reaction rather than a sincere protection of the masses result. A drug that is invented and tested in the USA and may have life saving results should be available in the USA.However, the FDA's CYA regulations that make companies pay up to a Billion dollars for more test over a period of over 10 years to do more and more testing..is an over reach by the government. Medical Tourism for life saving medication is NOT be the norm, which it is today in the USA. Support the Goldwater Institute's efforts to make available life saving medication to the same people that actually invented it and the masses.
MPCIRHC.ORG's curator insight, July 16, 2014 11:26 AM

Unfortunately, when an unfortunate event happens in the USA, the less informed cease upon that event to involve government more into the lives of others. This seems to be more of a CYA knee jerk reaction rather than a sincere protection of the masses result. A drug that is invented and tested in the USA and may have life saving results should be available in the USA.However, the FDA's CYA regulations that make companies pay up to a Billion dollars for more test over a period of over 10 years to do more and more testing..is an over reach by the government. Medical Tourism for life saving medication is NOT be the norm, which it is today in the USA. Support the Goldwater Institute's efforts to make available life saving medication to the same people that actually invented it and the masses.
Sign up to comment
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
April 11, 2014 3:36 PM
Scoop.it!

Phase 1 Trial for ALS Results of Novel Stem-Cell Therapy Presented By Neuralstem Representative

Phase 1 Trial for ALS Results of Novel Stem-Cell Therapy Presented By Neuralstem Representative | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From bionews-tx.com - April 11, 2014 3:36 PM
Read about how the Phase 1 Trial for ALS Results of Novel Stem-Cell Therapy Presented By Neuralstem Representative.
more...
No comment yet.
Sign up to comment
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
December 11, 2012 7:29 AM
Scoop.it!

Neuralstem Investigator Presents New ALS NSI-566 Data at International Symposium on ALS/MND

Neuralstem Investigator Presents New ALS NSI-566 Data at International Symposium on ALS/MND | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From www.heraldonline.com - December 11, 2012 7:29 AM

Neuralstem, Inc. (NYSE MKT: CUR) announced that Jonathon Glass, MD, Director of the Emory ALS Center, presented new data from the Phase I trial of Neuralstem's human spinal cord stem cells, NSI-566, in amyotrophic lateral sclerosis...

more...
No comment yet.
Sign up to comment
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
October 10, 2012 8:08 AM
Scoop.it!

Dr.Eva Feldman, Updates Interim Data On Completed Neuralstem ALS Phase I Trial...

From investor.neuralstem.com - October 10, 2012 8:08 AM
Dr.Eva Feldman, Principal Investigator, Updates Interim Data On Completed Neuralstem ALS Phase I Trial...
more...
No comment yet.
Sign up to comment
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
June 19, 2012 1:43 PM
Scoop.it!

Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial

Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From www.prnewswire.com - June 19, 2012 1:43 PM
Neuralstem, Inc. announced that the first patient to receive stem cell transplantation in both regions of the spinal cord has been treated in the ongoing Phase I trial of its spinal cord neural stem cells in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). This is.........
more...
No comment yet.
Sign up to comment
About Follow us Resources Terms Mobile Features
Facebook
X
LinkedIn